Clariane stock rebounds 2% but remains below its three moving averages
The stock of the group specializing in nursing homes, clinics and home care services is gaining ground this Tuesday in a modestly advancing Paris market. The rebound occurs in a tense technical context, with the price remaining below its three moving averages despite today's momentum.
A rebound of nearly 2% that places Clariane among the best performers of the SBF 120
Clariane gains 1.96% during the session and is trading at €3.84, while the SBF 120 advances 0.33% and the CAC 40 rises 0.30%. This movement places the stock among the strongest gainers in the broader index. The advance echoes the rebound of September 21, when the stock defended its support at €3.80 with a surge of 3.5%.
The current price stands just above this level at €3.77, giving it the role of an immediate floor. The sector comparison with Emeis, whose stock gains 0.73% during the session, shows that Clariane significantly outperforms its peers today in the personal services sector.
A strengthened financial context but moving averages still weighing on momentum
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The price remains below the 20-day MA at €3.95, the 50-day MA at €3.98 and the 200-day MA at €3.94, with respective gaps of 2.78%, 3.52% and 2.54%. This triple alignment below the moving averages reflects an underlying momentum still oriented downward, despite today's rebound. The RSI at 39 remains in the low zone without signaling clear oversold conditions, which leaves the configuration open. Over one month, the stock is down 1.39% and over three months down 9.22%, illustrating persistent pressure on the security.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 2 699 millions d'euros
Quarterly revenue: 2 699 millions d'euros
Revenue growth: 1,6 %
EBITDA: 524 millions d'euros
EBITDA margin: 10,4 %
Net income: -47,5 millions d'euros
Free cash flow: 20 millions d'euros
3 020 millions d'euros
Guidance from the release
Le Groupe s'appuiera principalement sur la poursuite de l'amélioration de la performance opérationnelle et le maintien d'une stricte discipline d'investissements
Risks mentioned
Environnement géopolitique complexe affectant les opérations de refinancement
Exposition aux épisodes climatiques frappant durement certains territoires en Europe
Pression inflationniste continue sur les coûts opérationnels malgré les gains tarifaires
Opportunities identified
Amélioration de la marge EBITDA de 100-150 points de base d'ici fin 2026
Croissance des volumes d'activité portée par l'augmentation progressive des taux d'occupation
Refinancement réussi de €1 063m renforçant la flexibilité financière et réduisant le coût de la dette
Outlook / guidance
Expected revenue: 5 522 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.